Enorama Pharma AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	17.76	3.04	2.09	6.15	4.14	12.2
Cash & Short-Term Investments	17.76	3.04	2.09	6.15	4.14	12.2
Cash Growth	282.14%	45.66%	-66.11%	48.66%	-66.07%	157.71%
Accounts Receivable	1.06	1.72	0.21	0.02	1.95	7.06
Other Receivables	0.49	0.93	1.2	2.03	2.37	1.45
Receivables	1.55	2.65	1.41	2.05	4.32	8.5
Inventory	1.87	1.75	11.28	4.29	2.84	1.24
Prepaid Expenses	1.59	0.56	0.39	0.47	0.45	0.47
Other Current Assets	-0	-0	-	-	-	-
Total Current Assets	22.77	8	15.16	12.96	11.75	22.41
Property, Plant & Equipment	0.01	0.01	0.14	0.86	1.54	2.22
Long-Term Deferred Charges	0.17	0.25	0.59	20.56	23.43	26.3
Other Long-Term Assets	-	-0	-	-	12	-
Total Assets	22.95	8.26	15.89	34.39	48.72	50.93
Accounts Payable	5.68	6.5	1.17	3.72	5.35	2.18
Accrued Expenses	3.25	2.81	1.5	4.02	2.04	2.24
Current Portion of Long-Term Debt	-	-	-	0.13	1.46	2.09
Current Income Taxes Payable	-	-	-	0.29	0.43	0.39
Other Current Liabilities	26.44	22.41	5.43	2.06	3.14	4.79
Total Current Liabilities	35.37	31.71	8.09	10.22	12.43	11.68
Long-Term Debt	-	-	-	0.3	0.45	1.7
Other Long-Term Liabilities	24.21	-	-	4.33	4.33	16.2
Total Liabilities	59.58	31.71	8.09	14.85	17.2	29.58
Common Stock	11.66	11.66	9.45	6.39	1.46	1.2
Additional Paid-In Capital	270.15	270.15	237.99	205.32	176.55	126.45
Retained Earnings	-318.44	-305.25	-239.64	-192.18	-149.07	-106.29
Comprehensive Income & Other	-	-	-	-	2.58	-
Shareholders' Equity	-36.64	-23.45	7.8	19.54	31.52	21.35
Total Liabilities & Equity	22.95	8.26	15.89	34.39	48.72	50.93
Total Debt	-	-	-	0.44	1.91	3.79
Net Cash (Debt)	17.76	3.04	2.09	5.72	2.23	8.41
Net Cash Growth	282.14%	45.66%	-63.53%	156.37%	-73.49%	-
Net Cash Per Share	-	0.04	0.04	0.21	0.28	1.36
Filing Date Shares Outstanding	-	74.59	60.47	40.93	25.86	7.69
Total Common Shares Outstanding	-	74.59	60.47	40.93	9.35	7.69
Working Capital	-12.6	-23.72	7.07	2.75	-0.67	10.73
Book Value Per Share	-	-0.31	0.13	0.48	3.37	2.78
Tangible Book Value	-36.64	-23.45	7.8	19.54	31.52	21.35
Tangible Book Value Per Share	-	-0.31	0.13	0.48	3.37	2.78
Machinery	-	2.12	2.15	3.37	3.37	3.37

Source: S&P Global Market Intelligence. Standard template. Financial Sources.